After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

“Philanthropic support plays a critical role in accelerating the development of these new, transformative treatments,” said ...

Human Amniotic Epithelial Stem Cells is under clinical development by iCELL Biotechnology and currently in Phase I for Parkinson's Disease.

In the heart of the McGill University Health Centre’s research institute, Dr. Renzo Cecere and his team are revolutionizing the future of cardiac care.

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

Mesenchymal Stromal Cell Therapy is under clinical development by Orbsen Therapeutics and currently in Phase II for Crohn's Disease (Regional Enteritis).

Researchers developed spatial aging clocks to map brain cell aging, revealing how T cells accelerate aging and NSCs ...

Building on the work of Dr. Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells ... for this miracle therapy. Millions of children ...